Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Using “All Available Tools” To Remove DMAA From Market

This article was originally published in The Tan Sheet

Executive Summary

FDA issues a consumer warning about the potentially lethal effects of DMAA, and promises to use “all available tools at its disposal to ensure the dietary supplements containing” the stimulant “are no longer distributed and available for sale.”

Advertisement

Related Content

Second Warning, Second Unsafe Ingredient For Total Body Nutrition
More Criminal Cases Likely In Supplement, Food Safety, DoJ Official Says
More Criminal Cases Likely In Supplement, Food Safety, DoJ Official Says
More Criminal Cases Likely In Supplement, Food Safety, DoJ Official Says
More Criminal Cases Likely In Supplement, Food Safety, DoJ Official Says
Hi-Tech Lawsuit Calls FDA DMAA Enforcement “Bullying Tactics”
DMAA Is Synthetic And Needs NDI Notification – Study
DMAA Warnings Shed Light On FDA NDI Enforcement
U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales
Supreme Court Refuses Ephedra Case, Battle Against Risk-Benefit Continues

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel